Cargando…

Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells

The fetal isoform A of the insulin receptor (IR-A) is frequently overexpressed in a variety of malignancies including breast cancer. IR overexpression has a recognized role in cancer progression and resistance to anticancer therapies. In particular, IR-A has a peculiar mitogenic potential and is act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vella, Veronica, Malaguarnera, Roberta, Nicolosi, Maria Luisa, Palladino, Chiara, Spoleti, Cristina, Massimino, Michele, Vigneri, Paolo, Purrello, Michele, Ragusa, Marco, Morrione, Andrea, Belfiore, Antonino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522143/ https://www.ncbi.nlm.nih.gov/pubmed/28591735 http://dx.doi.org/10.18632/oncotarget.18020

Ejemplares similares

Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation
por: Vella, Veronica, et al.
Publicado: (2019)

Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer
por: Buraschi, Simone, et al.
Publicado: (2020)

IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway
por: Matà, Roberta, et al.
Publicado: (2015)

Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
por: Malaguarnera, Roberta, et al.
Publicado: (2017)

Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells
por: Vella, Veronica, et al.
Publicado: (2021)

Insulin Receptor Isoforms Differently Regulate Cell Proliferation and Apoptosis in the Ligand-Occupied and Unoccupied State
por: Massimino, Michele, et al.
Publicado: (2021)

Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses
por: Malaguarnera, Roberta, et al.
Publicado: (2015)

The Insulin Receptor: A New Target for Cancer Therapy
por: Malaguarnera, Roberta, et al.
Publicado: (2011)

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
por: Vella, Veronica, et al.
Publicado: (2017)

Ligand-Mediated Endocytosis and Trafficking of the Insulin-Like Growth Factor Receptor I and Insulin Receptor Modulate Receptor Function
por: Morcavallo, Alaide, et al.
Publicado: (2014)

The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives
por: Vella, Veronica, et al.
Publicado: (2018)

The Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells
por: Malaguarnera, Roberta, et al.
Publicado: (2014)

Phosphoproteomic analysis identifies insulin enhancement of discoidin domain receptor 2 phosphorylation
por: Iwai, Leo K., et al.
Publicado: (2013)

Editorial: Clinical and Molecular Epidemiology of Thyroid Cancer of Follicular Origin
por: Malaguarnera, Roberta, et al.
Publicado: (2018)

Discoidin Domain Receptors: Potential Actors and Targets in Cancer
por: Rammal, Hassan, et al.
Publicado: (2016)

Collagen recognition and transmembrane signalling by discoidin domain receptors()
por: Carafoli, Federico, et al.
Publicado: (2013)

Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer
por: Chen, Li, et al.
Publicado: (2021)

Control of craniofacial development by the collagen receptor, discoidin domain receptor 2
por: Mohamed, Fatma F, et al.
Publicado: (2023)

Insulin Receptor Isoforms in Cancer
por: Vella, Veronica, et al.
Publicado: (2018)

DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System
por: Vella, Veronica, et al.
Publicado: (2021)

The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
por: Malaguarnera, Roberta, et al.
Publicado: (2012)

Obesity, Diabetes, and Cancer: The Role of the Insulin/IGF Axis; Mechanisms and Clinical Implications
por: Morrione, Andrea, et al.
Publicado: (2022)

Crystallographic Insight into Collagen Recognition by Discoidin Domain Receptor 2
por: Carafoli, Federico, et al.
Publicado: (2009)

Corrigendum: Discoidin Domain Receptors: Potential Actors and Targets in Cancer
por: Rammal, Hassan, et al.
Publicado: (2016)

Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
por: Denny, William A., et al.
Publicado: (2021)

Focusing on discoidin domain receptors in premalignant and malignant liver diseases
por: Gong, Hang, et al.
Publicado: (2023)

Recombinant Collagen Engineered to Bind to Discoidin Domain Receptor Functions as a Receptor Inhibitor
por: An, Bo, et al.
Publicado: (2016)

Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells
por: Stella, Stefania, et al.
Publicado: (2023)

Expression of Concern: Discoidin Domain Receptors: Potential Actors and Targets in Cancer
Publicado: (2016)

Discoidin domain receptors: Microenvironment sensors that promote cellular migration and invasion
por: Itoh, Yoshifumi
Publicado: (2018)

Discoidin domain receptor regulates ensheathment, survival and caliber of peripheral axons
por: Corty, Megan M., et al.
Publicado: (2022)

Discoidin Domain Receptor 1 Contributes to Tumorigenesis through Modulation of TGFBI Expression
por: Rudra-Ganguly, Nandini, et al.
Publicado: (2014)

Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma
por: Hur, Hoon, et al.
Publicado: (2017)

Discoidin Domain Receptors 1 Inhibition Alleviates Osteoarthritis via Enhancing Autophagy
por: Chou, Hsin-Chaio, et al.
Publicado: (2020)

N-Glycosylation of the Discoidin Domain Receptor Is Required for Axon Regeneration in Caenorhabditis elegans
por: Shimizu, Tatsuhiro, et al.
Publicado: (2019)

Discoidin domain receptors orchestrate cancer progression: A focus on cancer therapies
por: Gao, Yuan, et al.
Publicado: (2021)

Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact
por: Ben Arfi, Kaouther, et al.
Publicado: (2022)

Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease
por: Borza, Corina M., et al.
Publicado: (2022)

Endothelial discoidin domain receptor 1 senses flow to modulate YAP activation
por: Liu, Jiayu, et al.
Publicado: (2023)

Protective effects of genetic inhibition of Discoidin Domain Receptor 1 in experimental renal disease
por: Kerroch, Monique, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hvjmv7ksmc393ju9qdsrra8lu6